Agenus, Inc. (AGEN)
6.33
-0.18
(-2.76%)
USD |
NASDAQ |
Oct 23, 16:00
6.32
-0.01
(-0.16%)
After-Hours: 20:00
Agenus Market Cap : 269.76M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 269.76M |
| October 22, 2026 | 277.43M |
| October 21, 2026 | 272.74M |
| October 20, 2026 | 273.59M |
| October 19, 2026 | 263.36M |
| October 16, 2026 | 257.40M |
| October 15, 2026 | 284.67M |
| October 14, 2026 | 277.00M |
| October 13, 2026 | 296.18M |
| October 12, 2026 | 316.63M |
| October 09, 2026 | 326.86M |
| October 08, 2026 | 321.32M |
| October 07, 2026 | 322.60M |
| October 06, 2026 | 319.19M |
| October 05, 2026 | 372.03M |
| October 02, 2026 | 356.27M |
| October 01, 2026 | 354.99M |
| September 30, 2026 | 423.17M |
| September 29, 2026 | 421.47M |
| September 28, 2026 | 401.87M |
| September 25, 2026 | 363.94M |
| September 24, 2026 | 362.23M |
| September 23, 2026 | 357.97M |
| September 22, 2026 | 370.76M |
| September 21, 2026 | 354.99M |
| Date | Value |
|---|---|
| September 18, 2026 | 334.53M |
| September 17, 2026 | 307.68M |
| September 16, 2026 | 307.26M |
| September 15, 2026 | 305.13M |
| September 14, 2026 | 303.85M |
| September 11, 2026 | 295.75M |
| September 10, 2026 | 293.62M |
| September 09, 2026 | 292.34M |
| September 08, 2026 | 316.63M |
| September 04, 2026 | 351.15M |
| September 03, 2026 | 351.15M |
| September 02, 2026 | 344.76M |
| September 01, 2026 | 340.50M |
| August 31, 2026 | 324.30M |
| August 28, 2026 | 326.44M |
| August 27, 2026 | 332.83M |
| August 26, 2026 | 351.58M |
| August 25, 2026 | 356.27M |
| August 24, 2026 | 326.86M |
| August 21, 2026 | 344.76M |
| August 20, 2026 | 319.19M |
| August 19, 2026 | 352.00M |
| August 18, 2026 | 320.90M |
| August 17, 2026 | 304.70M |
| August 14, 2026 | 311.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 14.33B |
| AVITA Medical, Inc. | 479.67M |
| Iovance Biotherapeutics, Inc. | 6.382B |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
Market Cap Related Metrics
| PE Ratio | 2.388 |
| PS Ratio | 1.763 |
| Price | 6.33 |
| Earnings Yield | 41.88% |
| Operating PE Ratio | 6.518 |
| Normalized PE Ratio | 6.341 |